Physician profile
Subhash J Patel
NPI 1891986907
$5,416.42
in general payments reported to CMS, 2019-2025
25 companies · $939 in 2025
The $939 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,789 · 2020: $358 · 2021: $339 · 2022: $488 · 2023: $800 · 2024: $704 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,443.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,815.48 | 2019-2020 | |
| Edwards Lifesciences Corporation | $605.97 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $410.85 | 2021-2024 | Corevalve Evolut R |
| W. L. Gore & Associates, INC. | $370.53 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis |
| Boston Scientific Corporation | $338.43 | 2019-2024 | Watchman Access System |
| Abbott Laboratories | $249.85 | 2019-2023 | Dragonfly Opstar |
| Penumbra, INC. | $248.04 | 2024 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.98 | 2020-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $226.80 | 2022-2025 | |
| Ge Healthcare | $195.20 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $121.18 | 2025 | Camzyos |
| Bard Peripheral Vascular, INC. | $100.00 | 2023 | |
| Zoll Circulation INC | $80.45 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Janssen Pharmaceuticals, INC | $75.74 | 2020-2021 | |
| Amgen INC. | $66.77 | 2025 | Repatha |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $63.45 | 2022 | |
| Philips North America LLC | $53.17 | 2022-2023 | |
| Genentech USA, INC. | $26.93 | 2025 | Ocrevus Zunovo |
| Biotronik INC. | $23.07 | 2024 | Pk Papyrus |
| Teleflex LLC | $20.53 | 2023 | Manta |
| Angiodynamics, INC. | $19.79 | 2023 | Angiovac |
| Bayer Healthcare Pharmaceuticals INC. | $19.38 | 2023 | |
| Cook Medical LLC | $17.99 | 2022 | |
| Pfizer INC. | $14.51 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.